Research programme: inflammation therapy - Topigen

Drug Profile

Research programme: inflammation therapy - Topigen

Alternative Names: Inflammation therapy research programme - Topigen; TOP 4; TOP 5; TOP04; TOP05

Latest Information Update: 14 Dec 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Topigen Pharmaceuticals
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 31 Dec 2007 Discontinued - Preclinical for Inflammation in Canada (unspecified route)
  • 22 Jun 2005 Preclinical trials in Inflammation in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top